Beta Drugs Ltd Financial Statement
*All values are in Rs. Cr
No Data Available
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 220.20 | 197.62 | 157.87 |
| Operating Expenses Annual | 188.78 | 164.10 | 126.68 |
| Operating Profit Annual | 33.04 | 35.26 | 32.24 |
| Interest Annual | 4.76 | 1.05 | 0.84 |
| Depreciation | 7.44 | 4.72 | 6.19 |
| Net Profit Annual | 15.43 | 21.94 | 18.82 |
| Tax Annual | 5.41 | 7.55 | 6.39 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 220.20 |
| Operating Expenses Annual | 188.78 |
| Operating Profit Annual | 33.04 |
| Interest Annual | 4.76 |
| Depreciation | 7.44 |
| Net Profit Annual | 15.43 |
| Tax Annual | 5.41 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 27.20 | 17.79 | 15.58 |
| Cash Flow from Operations | 18.04 | 21.19 | 10.23 |
| Cash Flow from Investing | -21.46 | -11.02 | -5.82 |
| Cash Flow from Financing | 118.20 | -0.76 | -2.19 |
| Cash Flow at the End | 141.99 | 27.20 | 17.79 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 27.20 |
| Cash Flow from Operations | 18.04 |
| Cash Flow from Investing | -21.46 |
| Cash Flow from Financing | 118.20 |
| Cash Flow at the End | 141.99 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 17.08 | 17.84 | 20.42 |
| PBIT Margin (%) | 13.70 | 15.45 | 16.50 |
| PBT Margin (%) | 10.82 | 0.73 | -3.14 |
| Net PROFIT Margin (%) | 7.01 | 11.10 | 11.92 |
| Return On Networth / Equity (%) | 15.30 | 20.67 | 21.67 |
| Return On Networth /Employed (%) | 15.57 | 26.60 | 27.20 |
| Return On Assets (%) | 7.99 | 19.10 | 19.67 |
| Total Debt / Equity (X) | 0.54 | 0.05 | 0.07 |
| Asset Turnover Ratio (%) | 1.14 | 1.72 | 1.65 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 17.08 |
| PBIT Margin (%) | 13.70 |
| PBT Margin (%) | 10.82 |
| Net PROFIT Margin (%) | 7.01 |
| Return On Networth / Equity (%) | 15.30 |
| Return On Networth /Employed (%) | 15.57 |
| Return On Assets (%) | 7.99 |
| Total Debt / Equity (X) | 0.54 |
| Asset Turnover Ratio (%) | 1.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 53.48 | 36.48 | 34.77 |
| Total Current Assets Annual | 240.31 | 113.67 | 85.00 |
| Non Current Assets Annual | 76.21 | 56.80 | 49.04 |
| Total Shareholders Funds Annual | 129.04 | 116.01 | 96.26 |
| Total Assets Annual | 316.52 | 170.47 | 134.04 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 53.48 |
| Total Current Assets Annual | 240.31 |
| Non Current Assets Annual | 76.21 |
| Total Shareholders Funds Annual | 129.04 |
| Total Assets Annual | 316.52 |
No Data Availabe
